Matsubara Akio

J-GLOBAL         Last updated: Feb 27, 2019 at 18:21
 
Avatar
Name
Matsubara Akio
E-mail
matsuahiroshima-u.ac.jp
Affiliation
Hiroshima University
Degree
Doctor of Philosophy in Medical Science(Hiroshima University)
Research funding number
10239064

Research Areas

 
 

Academic & Professional Experience

 
Nov 1998
 - 
Mar 2001
Research Associate, Medical Hospital, Hiroshima University
 
Apr 2001
 - 
Sep 2002
Lecturer, Medical Hospital, Hiroshima University
 
Oct 2002
 - 
Mar 2007
Associate Professor, Graduate School of Biomedical Sciences, Hiroshima University
 
Apr 2007
 - 
Sep 2008
Associate Professor, Graduate School of Biomedical Sciences, Hiroshima University
 
Oct 2008
 - 
Mar 2012
Professor, Graduate School of Biomedical Sciences, Hiroshima University
 

Education

 
Apr 1979
 - 
Mar 1985
Hiroshima University
 

Published Papers

 
Inoue, Shogo; Kajiwara, Mitsuru; Teishima, Jun; Matsubara, Akio
ASIAN JOURNAL OF SURGERY   39(1) 6-11   Jan 2016   [Refereed]
Objective: Our objective was to compare the perioperative parameters of needle assisted and conventional laparoendoscopic single-site adrenalectomy (LESS-A). Methods: We compared 23 patients undergoing needle-assisted LESS-A with 29 patients under...
Inoue, Keiji; Matsuyama, Hideyasu; Fujimoto, Kiyohide; Hirao, Yoshihiko; Watanabe, Hironobu; Ozono, Seiichiro; Oyama, Masafumi; Ueno, Munehisa; Sugimura, Yoshiki; Shiina, Hiroaki; Mimata, Hiromitsu; Azuma, Haruhito; Nagase, Yasushi; Matsubara, Akio; Ito, Yoichi M.; Shuin, Taro
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY   13 91-96   Mar 2016   [Refereed]
Objective: To examine the utility and safety of photodynamic diagnosis (PDD) after oral administration of 5-aminolevulinic acid (5-ALA) (ALA-PDD) of non-muscle-invasive bladder cancer (NMIBC) using fluorescent-light (FL)-cystoscopy. Methods: The s...
Hayashi T, Gust KM, Wyatt AW, Goriki A, Jäger W, Awrey S, Li N, Oo HZ, Altamirano-Dimas M, Buttyan R, Fazli L, Matsubara A, Black PC.
Clinical Cancer Research   22(12) 2981-2992   Jun 2016   [Refereed]
Purpose: Recent molecular analyses of bladder cancer open the door to significant advances in targeted therapies. NOTCH has been identified as a tumor suppressor in bladder cancer, but prior reports have focused on NOTCH1. Here we hypothesized tha...
Honda, Yukiko; Goto, Keisuke; Sentani, Kazuhiro; Yasui, Wataru; Ikeda, Kenichiro; Matsubara, Akio; Awai, Kazuo
AMERICAN JOURNAL OF ROENTGENOLOGY   204(4) 792-797   Apr 2015   [Refereed]
OBJECTIVE. The purposes of this study were to propose and evaluate new diagnostic criteria for the differentiation of category T2 or lower from T3 or higher ureteral urothelial carcinomas on contrast-enhanced CT (CECT) images and to investigate th...
Inoue, Shogo; Kajiwara, Mitsuru; Teishima, Jun; Matsubara, Akio
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL   9(1-2) E1-E4   Jan 2015   [Refereed]
Introduction: The aim of this study was to better understand the impact that public opinion might have on surgical approaches in urologic minimally invasive surgery (MIS). Methods: We collected surveys from 400 participants, including the general ...

Books etc

 
Expression of fibroblast growth factors and fibroblast growth factor receptors in human benign prostatic hyperplasia: Comparison between epithelium and stroma.
Adenine Press   Dec 1994   

Conference Activities & Talks

 
Needlescopic-assisted laparoendoscopic single-site (LESS) adrenalectomy.
Shogo Inoue
AUA Annual Meeting 2014   May 2014   AUA 
Restoration of Fibroblast Growth Factor Receptor 2IIIb Enhances the Chemosensitivity of Human Prostate Cancer Cells.
Koichi Shoji
AUA Annual Meeting 2014   May 2014   AUA 
FGF19 subfamily promotes progression in prostate cancer cells.
Hirotaka Nagamatsu
AUA Annual Meeting 2014   May 2014   AUA
Prognostic impact of immunohistochemical classification of bladder cancer according to luminal (Uroplakin III) and basal (Cytokeratin 5/6) markers
T. Hayashi, K. Sentani, S. Kakumoto, H.Z. Oo, N. Sakamoto, K. Mutaguchi, K. Kobatake, K. Goto, S. Inoue, J. Teishima, W. Yasui, P.C. Black, A. Matsubara
32nd Annual EAU Congress London   26 Mar 2017   EAU
T-DM1, a novel HER2 antibody-cytotoxic drug conjugate, has anti- metastatic potential and is a promising targeted therapy for bladder cancer with HER2 IHC score 2+/3+
T. Hayashi, H. Oo, W. Jäger, K. Kobatake, A. Goriki, R. Seiler, T. Todenhöfer, N. Li, L. Fazli, A. Matsubara, P. Black
32nd Annual EAU Congress London   27 Mar 2017   EAU